----item----
version: 1
id: {74437101-B46A-454A-A5C0-E086CC27A1F8}
database: master
path: /sitecore/content/Pharma/MedtechInsight/Home/Articles/Timeline The PIP breast implant crisis
parent: {D5B965D3-AC3D-4A7F-90E6-65193022C6B5}
name: Timeline The PIP breast implant crisis
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----field----
field: {A4F985D9-98B3-4B52-AAAF-4344F6E747C6}
name: __Workflow
key: __workflow
content-length: 38

{926E6200-EB76-4AD4-8614-691D002573AC}
----version----
language: en
version: 1
revision: e545831c-458f-4de7-8d14-f09d6203e8ca

----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 4745

<p>  <tbody> <tr> <td><div>More on the PIP case </div></td> </tr> <tr> <td><div></div></td> <td><p><a>Rebranded PIP breast implants &ndash; many women in UK and other countries "unaware" of risks (15 February 2011)</a> <br> Evidence has emerged that PIP implants rebranded by Dutch firm Rofil Medical have been widely used by &ldquo;health tourism&rdquo; clinics around the world. This means that the number of women affected by the PIP fraud internationally &ndash; officially 50,000 in the UK alone and 30,000 in France, for example &ndash; is likely to be significantly greater than previously thought.<br> </p></td> </tr> <tr> <td><div></div></td> <td><p><a>Initial PIP silicone filler tests &ldquo;encouraging&rdquo; &ndash; MHRA (3 September 2010)</a> <br> Preliminary testing of the silicone filler used in banned breast implants made by Poly Implant Proth&egrave;se (PIP) has revealed &ldquo;no evidence of genotoxicity or chemical toxicity&rdquo;, the UK&rsquo;s Medicines and Healthcare products Regulatory Agency (MHRA) announced.<br> </p></td> </tr> <tr> <td><div></div></td> <td><p><a>Europe on alert as banned &ldquo;Rofil-branded PIP&rdquo; breast implants surface in Portugal (18 August 2010)</a> <br> Portuguese doctors have been warned against using breast implants marketed by Dutch firm Rofil Medical Nederland, marking a further twist in the crisis involving the fraudulent implants made by Poly Implant Proth&egrave;se (PIP) of France.<br> </p></td> </tr> <tr> <td><div><a></a></div></td> <td><p><a>600,000 implants per year &ndash; PIP output target in 2008 (13 May 2010)</a> <br> Poly Implant Proth&egrave;se (PIP), the now defunct manufacturer of fraudulent silicone breast implants, was producing some 160,000 implants per year in early 2007, and was set to increase production to 600,000 units by the end of 2008.<br> </p></td> </tr> <tr> <td><div><a></a></div></td> <td><p><a>Australian PIP implant surgery promises new insight into failures (11 May 2010)</a> <br> An Australian recipient of the controversial Poly Implant Proth&egrave;se (PIP) implants has undergone replacement surgery for the second time on the same breast in less than two months.<br> </p></td> </tr> <tr> <td><div><a></a></div></td> <td><p><a>Nagor in plans to relieve PIP crisis with UK implant replacement scheme &ndash; UPDATE (26 April 2010)</a> <br> UK aesthetic surgery implant manufacturer Nagor is collaborating with the British Association of Aesthetic Plastic Surgeons (BAAPS) to set up a scheme to help replace silicone breast implants made by Poly Implant Proth&egrave;se (PIP), <em>Clinica</em> has learned.<br> </p></td> </tr> <tr> <td><div><a></a></div></td> <td><p><a>Disparities emerge in reactions to PIP breast implants ban (14 April 2010)</a> <br> Disparities have emerged in how healthcare authorities, clinicians and patients are reacting to the situation surrounding the banned Poly Implant Proth&egrave;se (PIP) silicone breast implants.<br> </p></td> </tr> <tr> <td><div><a></a></div></td> <td><p><a>PIP breast implants "untraceable", registry now urgent &ndash; Italian govt (9 April 2010)</a> <br> The country's under-secretary of state for health called on the "professionalism and conscience" of the country's surgeons in order to help the government "verify whether the defective implants have been implanted in Italy". <br> </p></td> </tr> <tr> <td><div></div></td> <td><p><a>Spectre of widespread breast explantations returns with PIP recall (1 April 2010)</a><br> The PIP case is reminiscent of the Trilucent soya-oil breast implants case that erupted in June 2000.  </p></td> </tr> <tr> <td><div><a></a></div></td> <td><p><a>French company replaces product material and sees product banned (31 March 2010) </a> <br> The French medtech regulator, AFSSAPS, has suspended the sale, use, distribution and export of breast implants pre-filled with silicone gel manufactured by Poly Implant Prosth&egrave;se.<br> </p></td> </tr> <tr> <td><div><a></a></div></td> <td><p><a>The homepage: Poly Implant Proth&egrave;se (Clover Leaf Products)</a> <br> The website of the UK distributor of the PIP implant, Clover Leaf Products, was taken down recently. <em>Clinica</em> has a copy of the HTML document of the homepage.<br> </p></td> </tr> <tr> <td><div><a></a></div></td> <td><p><a>$100 million liability? Twist in the tale of Trilucent implant case (September 2002)</a> <br> In the case of Trilucent (as summarised before its conclusion, in <em>Clinica</em>'s sister publication <a>European Regulatory Affairs News</a>), around 10,500 women worldwide were implanted with around 17,000 implants. <br> </p></td> </tr> <tr> <td><p><span><em><a>Clinica - Policy & Regulation</a></em></span><br> </p></td> </tr> </tbody>  </p>
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 39

Timeline: The PIP breast implant crisis
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 9618

<p> <table> <tbody> <tr> <td scope="row" colspan="2"><div>More on the PIP case </div></td> </tr> <tr> <td widtd="101" scope="row"><div><img src="-/media/1B4CE9C7778F4E768C2CEB9CB267E7E2.ashx" width="80" height="80"></div></td> <td widtd="901"><p><a href="http://www.clinica.co.uk/marketsector/other/Rebranded-PIP-breast-implants---many-women-in-UK-and-other-countries-unaware-of-risks-311310" target="_blank" class="optionsLink">Rebranded PIP breast implants &ndash; many women in UK and other countries "unaware" of risks (15 February 2011)</a> <br> Evidence has emerged that PIP implants rebranded by Dutch firm Rofil Medical have been widely used by &ldquo;health tourism&rdquo; clinics around the world. This means that the number of women affected by the PIP fraud internationally &ndash; officially 50,000 in the UK alone and 30,000 in France, for example &ndash; is likely to be significantly greater than previously thought.<br> </p></td> </tr> <tr> <td widtd="101" scope="row"><div><img src="http://www.clinica.co.uk/multimedia/archive/00123/breast_implant_pati_123115a.jpg" width="80" height="80"></div></td> <td widtd="901"><p><a href="http://www.clinica.co.uk/policyregulation/Initial-PIP-silicone-filler-tests-encouraging---MHRA-302284" target="_blank" class="optionsLink">Initial PIP silicone filler tests &ldquo;encouraging&rdquo; &ndash; MHRA (3 September 2010)</a> <br> Preliminary testing of the silicone filler used in banned breast implants made by Poly Implant Proth&egrave;se (PIP) has revealed &ldquo;no evidence of genotoxicity or chemical toxicity&rdquo;, the UK&rsquo;s Medicines and Healthcare products Regulatory Agency (MHRA) announced.<br> </p></td> </tr> <tr> <td widtd="101" scope="row"><div><img src="http://www.clinica.co.uk/multimedia/archive/00106/breast_implant_gel__106517a.jpg" width="80" height="80"></div></td> <td widtd="901"><p><a href="http://www.clinica.co.uk/policyregulation/Europe-on-alert-as-banned-Rofil-branded-PIP-breast-implants-surface-in-Portugal-301392?autnID=/contentstore/clinica/codex/6e459030-aad6-11df-8862-27eb9485523c.xml" target="_blank" class="optionsLink">Europe on alert as banned &ldquo;Rofil-branded PIP&rdquo; breast implants surface in Portugal (18 August 2010)</a> <br> Portuguese doctors have been warned against using breast implants marketed by Dutch firm Rofil Medical Nederland, marking a further twist in the crisis involving the fraudulent implants made by Poly Implant Proth&egrave;se (PIP) of France.<br> </p></td> </tr> <tr> <td widtd="101" scope="row"><div><img src="http://www.clinica.co.uk/multimedia/archive/00095/breast_implants_80x8_95269a.jpg" width="80" height="80" border="0" s/=""><a href="http://www.agrow.com/podcast/int2a.wma" target="_blank"></a></div></td> <td widtd="901"><p><a href="http://www.clinica.co.uk/policyregulation/600000-implants-per-year---PIP-output-target-in-2008-283419" target="_blank" class="optionsLink">600,000 implants per year &ndash; PIP output target in 2008 (13 May 2010)</a> <br> Poly Implant Proth&egrave;se (PIP), the now defunct manufacturer of fraudulent silicone breast implants, was producing some 160,000 implants per year in early 2007, and was set to increase production to 600,000 units by the end of 2008.<br> </p></td> </tr> <tr> <td widtd="101" scope="row"><div><img src="http://www.clinica.co.uk/multimedia/archive/00095/breast_implant_banda_95273a.jpg" width="80" height="80" border="0"><a href="http://www.agrow.com/podcast/int2a.wma" target="_blank"></a></div></td> <td widtd="901"><p><a href="http://www.clinica.co.uk/marketsector/Australian-PIP-implant-surgery-promises-new-insight-into-failures-280142?autnID=/contentstore/clinica/codex/15dde025-5d0b-11df-a344-4b68910a1c57.xml" target="_blank" class="optionsLink">Australian PIP implant surgery promises new insight into failures (11 May 2010)</a> <br> An Australian recipient of the controversial Poly Implant Proth&egrave;se (PIP) implants has undergone replacement surgery for the second time on the same breast in less than two months.<br> </p></td> </tr> <tr> <td widtd="101" scope="row"><div><img src="http://www.clinica.co.uk/multimedia/archive/00092/breast_implant_model_92600a.jpg"><a href="http://www.agrow.com/podcast/int2a.wma" target="_blank"></a></div></td> <td widtd="901"><p><a href="http://www.clinica.co.uk/policyregulation/policy/Nagor-in-plans-to-relieve-PIP-crisis-with-UK-implant-replacement-scheme---UPDATE-254263?autnID=/contentstore/clinica/codex/3f9b49b8-5127-11df-8fab-a1522d3ef0e5.xml" target="_blank" class="optionsLink">Nagor in plans to relieve PIP crisis with UK implant replacement scheme &ndash; UPDATE (26 April 2010)</a> <br> UK aesthetic surgery implant manufacturer Nagor is collaborating with the British Association of Aesthetic Plastic Surgeons (BAAPS) to set up a scheme to help replace silicone breast implants made by Poly Implant Proth&egrave;se (PIP), <em>Clinica</em> has learned.<br> </p></td> </tr> <tr> <td scope="row" widtd="101"><div><img src="http://www.clinica.co.uk/multimedia/archive/00051/breastscan_80x80_51788a.jpg" width="80" height="80"><a href="http://www.agrow.com/podcast/int2a.wma" target="_blank"></a></div></td> <td widtd="901"><p><a href="http://www.clinica.co.uk/policyregulation/policy/Disparities-emerge-in-reactions-to-PIP-breast-implants-ban-244467?autnID=/contentstore/clinica/codex/6de3dce2-47d5-11df-8fab-a1522d3ef0e5.xml" class="optionsLink">Disparities emerge in reactions to PIP breast implants ban (14 April 2010)</a> <br> Disparities have emerged in how healthcare authorities, clinicians and patients are reacting to the situation surrounding the banned Poly Implant Proth&egrave;se (PIP) silicone breast implants.<br> </p></td> </tr> <tr> <td scope="row" widtd="101"><div><img src="http://www.clinica.co.uk/multimedia/archive/00090/breast_implant_surge_90683a.jpg" width="80" height="80" border="0"><a href="http://www.agrow.com/podcast/int2a.wma" target="_blank"></a></div></td> <td widtd="901"><p><a href="http://www.clinica.co.uk/policyregulation/policy/PIP-breast-implants-untraceable-registry-now-urgent---Italian-govt-239583?autnID=/contentstore/clinica/codex/f1d24618-43e7-11df-8fab-a1522d3ef0e5.xml" class="optionsLink">PIP breast implants "untraceable", registry now urgent &ndash; Italian govt (9 April 2010)</a> <br> The country's under-secretary of state for health called on the "professionalism and conscience" of the country's surgeons in order to help the government "verify whether the defective implants have been implanted in Italy". <br> </p></td> </tr> <tr> <td scope="row"><div><img src="http://www.clinica.co.uk/multimedia/archive/00090/breast_implanr_surge_90702a.jpg" width="80" height="80"></div></td> <td><p><a href="http://www.clinica.co.uk/marketsector/Spectre-of-widespread-breast-explantations-returns-with-PIP-recall-227657?autnID=/contentstore/clinica/codex/d2c26bb7-3d7c-11df-8fab-a1522d3ef0e5.xml" class="optionsLink">Spectre of widespread breast explantations returns with PIP recall (1 April 2010)</a><br> The PIP case is reminiscent of the Trilucent soya-oil breast implants case that erupted in June 2000.  </p></td> </tr> <tr> <td widtd="101" scope="row"><div><img src="http://www.clinica.co.uk/multimedia/archive/00092/breast_implant_knife_92594a.jpg" width="80" height="80" border="0"><a href="http://www.agrow.com/podcast/int2a.wma" target="_blank"></a></div></td> <td widtd="901"><p><a href="http://www.clinica.co.uk/policyregulation/regulation/French-company-replaces-product-material-and-sees-product-banned-227608?autnID=/contentstore/clinica/codex/5d0608b2-3cc3-11df-8fab-a1522d3ef0e5.xml" class="optionsLink">French company replaces product material and sees product banned (31 March 2010) </a> <br> The French medtech regulator, AFSSAPS, has suspended the sale, use, distribution and export of breast implants pre-filled with silicone gel manufactured by Poly Implant Prosth&egrave;se.<br> </p></td> </tr> <tr> <td widtd="101" scope="row"><div><img src="http://www.clinica.co.uk/multimedia/archive/00092/breast_implant_surge_92599a.jpg" width="80" height="80"><a href="http://www.agrow.com/podcast/int2a.wma" target="_blank"></a></div></td> <td widtd="901"><p><a href="http://www.clinica.co.uk/multimedia/archive/00092/Cloverleaf_Medical_P_92597a.htm" target="_blank" class="optionsLink">The homepage: Poly Implant Proth&egrave;se (Clover Leaf Products)</a> <br> The website of the UK distributor of the PIP implant, Clover Leaf Products, was taken down recently. <em>Clinica</em> has a copy of the HTML document of the homepage.<br> </p></td> </tr> <tr> <td widtd="101" scope="row"><div><img src="http://www.clinica.co.uk/multimedia/archive/00092/breast_implant_model_92601a.jpg" width="80" height="80" border="0"><a href="http://www.agrow.com/podcast/int2a.wma" target="_blank"></a></div></td> <td widtd="901"><p><a href="http://www.clinica.co.uk/multimedia/archive/00090/trilucent_soya_breas_90703a.pdf" target="_blank" class="optionsLink">$100 million liability? Twist in the tale of Trilucent implant case (September 2002)</a> <br> In the case of Trilucent (as summarised before its conclusion, in <em>Clinica</em>'s sister publication <a href="http://www.rajdevices.com/" target="_blank" class="optionsLink">European Regulatory Affairs News</a>), around 10,500 women worldwide were implanted with around 17,000 implants. <br> </p></td> </tr> <tr> <td colspan="2" scope="row" widtd="101"><p><span class="style1"><em><a href="http://www.clinica.co.uk/policyregulation/policy/" class="optionsLink">Clinica - Policy & Regulation</a></em></span><br> </p></td> </tr> </tbody> </table> </p> 
----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 38

{2EDCC1FF-26E4-4C6E-AF73-0F43F0F033B8}
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 38

Timeline The PIP breast implant crisis
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20160622T185745
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

MT057984
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 39

Timeline: The PIP breast implant crisis
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{FF38DC83-07D4-43F0-8C55-84EB64FAF35A}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

311338
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160622T190249Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

e545831c-458f-4de7-8d14-f09d6203e8ca
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160622T225745Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 14

sitecore\admin
----field----
field: {3E431DE1-525E-47A3-B6B0-1CCBEC3A8C98}
name: __Workflow state
key: __workflow state
content-length: 38

{962542F5-554E-4DE8-BE4C-B0796FDAC854}
